Lifelight (Xim)

What Lifelight (Xim) does

Lifelight (Xim Limited) is a UK-based digital health company that has developed a software-only medical device for measuring blood pressure, pulse rate, and respiratory rate using only a smartphone or tablet camera. The core technology applies remote photoplethysmography (rPPG) and machine learning to detect micro-level facial color changes associated with each heartbeat, combined with a proprietary tiling-and-aggregation algorithm for dynamic region-of-interest selection. The product is certified as a CE Class IIa medical device under EU MDR and UK MDR, with ISO 13485:2016 and ISO 27001 certifications, four international patents, and validation through eight clinical trials including the VISION-D study covering 17,233 measurements from 8,585 participants.

Name

Lifelight (Xim)

Legal name

Xim Limited

Website

https://lifelight.ai

Company type

Private

Founded year

2009

Operating status

Operating

Headcount range

11–50 employees

Short description

Lifelight (Xim Limited) is a UK digital health company whose CE Class IIa-certified software measures blood pressure, pulse, and respiratory rate via smartphone camera using remote photoplethysmography, serving NHS providers, insurers, telehealth platforms, and medtech partners through SDK and SaaS deployments.

Ownership category

akta.pro rank

Product category

Digital Health Medical Device Software

NAICS

Research and Development in the Physical, Engineering, and Life Sciences (54171), Services for the Elderly and Persons with Disabilities (624120)

SIC

Services-Health Services (8000), Services-Home Health Care Services (8082), Services-Prepackaged Software (7372)

akta.pro primary industry

Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration) (HLACAPAI)

akta.pro secondary industries

Elderly/Frail & Assisted Living Connected Care (PERS/Fall Detection) (HLACAFAE), Home Patient Monitoring & Telehealth Devices (Vitals, Fall Detection, PERS) (HSABAKAE), Chronic Disease Remote Monitoring (COPD/CHF/HTN, Weight & Symptom Tracking) (HLAHACAI)

Keywords

• Contactless vital signs monitoring
• Remote photoplethysmography software
• Blood pressure measurement
• Digital health medical device
• Health monitoring SDK

Headquarters

HQ city

Southampton

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

1. SDK Licensing to Enterprise Partners: Lifelight generates revenue through licensing its SDK to enterprise customers including insurers (Sanitas), medtech companies (iPLATO), telehealth platforms (NowPatient), and healthcare providers. Partners integrate Lifelight into their existing apps to provide vital signs monitoring to their customers/users.
2. Direct NHS/Healthcare Provider Deployment: Revenue from direct deployment of Lifelight to NHS trusts, integrated care systems, and healthcare providers. Already available to 1,700 primary care practices as a 'software as a service'.
3. Lifelight Connect Consumer App: Lifelight Connect app distributed through Apple App Store and Google Play Store, enabling direct consumer access to blood pressure and vital signs monitoring.
4. White-Label/OEM Partnerships: White-label partnerships where Lifelight technology is embedded into partner brand applications, with revenue based on integration and usage agreements.

Pricing tiers

Go-to-market motion4 records

Distribution channels4 records

Marketing channels8 records

Core offering

Lifelight is a medically certified (CE Class IIa), software-only vital signs measurement platform that uses a standard smartphone or tablet camera and remote photoplethysmography (rPPG) to estimate blood pressure, pulse rate, and respiratory rate contactless in under 40 seconds, with no cuff, wearable, or calibration required. It is delivered as an embeddable Software Development Kit (SDK) for enterprise partners and as the Lifelight Connect consumer app, enabling use across NHS primary care, health insurance, telehealth, medtech, and pharmaceutical applications.

Product overview

Lifelight (Xim) offers a software-only vital signs measurement platform consisting of three interconnected products: the core Lifelight technology (a CE Class IIa medical device) that measures blood pressure and pulse using smartphone cameras via remote photoplethysmography; Lifelight Connect, a direct-to-consumer mobile app distributed through app stores; and the Lifelight SDK for third-party partners to integrate into their existing applications. The platform requires no additional hardware, cuffs, or calibration, making it suitable for home monitoring, clinical settings, and integration into health insurance, telehealth, and medtech applications.

Differentiator

Problem solved

Functional benefit

Brands

• Lifelight Connect: Mobile application developed and distributed by Xim that incorporates the Lifelight measurement engine for vital signs monitoring.

Products and services

• Lifelight A medically certified (CE Class IIa) software-only blood pressure and pulse measurement technology that uses smartphone/tablet cameras and remote photoplethysmography (rPPG) to capture vital signs contactlessly in under 40 seconds, with no hardware, cuff, or calibration required. It serves enterprise healthcare buyers including NHS trusts, insurers, pharma, medtech, and telehealth providers.
• Lifelight Connect A consumer-facing mobile application that incorporates the Lifelight measurement engine to allow individual users to monitor blood pressure and vital signs at home using their smartphone camera, available via Apple App Store (id6451387007) and Google Play Store (com.lifelight).
• Lifelight SDK A Software Development Kit that allows third-party organisations to embed Lifelight's contactless blood pressure and pulse measurement capabilities directly into their own native iOS and Android applications, enabling partners to act as Data Controllers while Xim provides the measurement technology.

Quantifiable outcome

• £300m+ annual NHS savings potential if used in GP surgeries alone
• +5 more outcomes

Named customers8 records

Segments6 records

Ideal customer profiles6 records

Technology focussed Yes

API detail

Has API

Yes

API docs

API detail

Core technology

AI maturity

App detail

Integration5 records

AI capability3 records

Feature8 records

Partnerships

Ten partnerships are on record, tiered minor and core.

• L Marks and Avencera (Thames Freeport)minorStrategic or Co-development Partner · 12 January 2026L Marks partnered with Avencera as part of Thames Freeport's delivery consortium to launch an eight-week mobile health screening pilot programme. Lifelight is one of seven healthtech companies integrated into the Thames Freeport Healthcare Innovation Lab, offering free diabetes and hypertension testing to communities across Barking & Dagenham, Havering, and Thurrock in the UK (January 12 - March 4, 2026).
• NowPatientcoreTechnology or Integration · 17 February 2025NowPatient, a leading global online pharmacy and telehealth service, integrated Lifelight's clinically validated blood pressure technology into their synchronous virtual care platform. This enables remote prescribing for medications that previously required in-person blood pressure readings. NowPatient is part of Infohealth Limited and serves users worldwide.
• Department for Business and Trade / ABHIminorGTM or Marketing Partner · 16 January 2025Lifelight exhibited at Arab Health 2025 in the UK Healthcare Pavilion, delivered by ABHI on behalf of the UK Department for Business and Trade. This supports international market expansion and visibility.
• SanitascoreStrategic or Co-development Partner · 5 November 2024Sanitas, one of Switzerland's largest health insurers with over 900,000 customers and premium income exceeding CHF 3 billion, embedded Lifelight vital signs into their Sanitas Portal app. The Chronic Journey feature focuses on detection of high blood pressure to help prevent, detect and manage cardiovascular disease. Over 100,000 users signed up within the first two weeks of launch. App available in German, French, Italian and English.
• iPLATO (myGP)coreTechnology or Integration · 27 March 2024iPLATO, part of Huma, integrated Lifelight into their myGP app making blood pressure monitoring available to 3 million users. The integration enables 3 million people to monitor hypertension via their smartphones, supporting NHS Long Term Plan's focus on preventive care and reducing health inequalities. Currently available on iOS with Android planned.
• Hampshire and Isle of Wight Integrated Care SystemcoreStrategic or Co-development Partner · 18 January 2023Hampshire and Isle of Wight ICS deployed Lifelight in a Digital Exemplar project to transform blood pressure measurement across the region. Lifelight was deployed in community and care home settings for rapid vital signs assessment without cuffs, wires, or physical contact. Supporting early detection of hypertension and reducing clinical risk and time.
• Lincolnshire Integrated Care BoardcoreStrategic or Co-development Partner · 1 January 2023Lincolnshire ICB developed a virtual ward using Lifelight allowing older patients with two or more chronic conditions to remain living at home. Over six months, 337 patients over 60 submitted 23,116 estimates, with over 10% diagnosed with previously undetected hypertension.
• Hampshire Hospitals NHS Foundation TrustcoreStrategic or Co-development Partner · 1 March 2022Hampshire Hospitals NHS Foundation Trust deployed Lifelight for remote monitoring of blood pressure and pulse in nursing homes, care homes, and a step-down facility. This enabled checking vital signs safely while minimizing travel costs.
• Welcome to the Jungle / OttaminorGTM or Marketing PartnerLifelight uses Welcome to the Jungle (Otta), a careers platform that helps people find roles at fast-growing companies. Prospective employees can view Lifelight's profile to learn about the mission and apply to live roles.
• NHScoreStrategic or Co-development PartnerLifelight is used by the UK's National Health Service, deployed across multiple NHS trusts and available to 1,700 primary care practices as a software-as-a-service offering.

Scale indicators13 records

Recent moves6 records

Expansion highlights7 records

Direct peers

• Aktiia: Swiss cuffless blood pressure monitoring company using optical PPG technology. Direct competitor to Lifelight in the contactless/cuffless BP space, particularly within European health systems and insurers.
• Binah.ai: Israel-based company offering contactless vital signs monitoring (heart rate, blood pressure, SpO2, respiration) via smartphone camera using rPPG/signal processing. Closest direct competitor to Lifelight's software-only approach.
• Nuralogix (Anura): Canadian company with Anura app delivering contactless health measurements via smartphone camera using rPPG and AI. Competes directly with Lifelight Connect on consumer/enterprise vitals measurement.
• Biobeat: Israel-based company offering cuffless continuous blood pressure and vital signs monitoring using PPG/rPPG-based sensors. Competes in the same remote patient monitoring and clinical vitals category as Lifelight.

Emerging players

• Caretaker Medical: Develops contactless continuous 'beat-to-beat' blood pressure and vital signs monitoring using finger PPG. Adjacent competitor focused on clinical environments rather than consumer smartphone use.
• Valencell: US PPG/biosensor technology company providing embedded optical heart rate and cuffless BP algorithms for wearables and hearables. Adjacent to Lifelight on PPG-based BP estimation technology.

Broad incumbents

• Withings: Established consumer health devices company (BPM Connect, Body Cardio, ScanWatch) offering connected blood pressure monitors and wearables. Comparable on the end-user outcome (home BP monitoring) though hardware-based.
• Philips (Remote Patient Monitoring): Large incumbent offering RPM, telehealth, and clinical-grade vital signs monitoring. Comparable on use cases (BP monitoring, remote patient management) but with hardware-centric solutions versus Lifelight's software-only model.
• Omron Healthcare: Global leader in home blood pressure monitors (cuff-based). Comparable on the hypertension-management end-user outcome but anchored to traditional cuff hardware versus Lifelight's software-only approach.

Others

• Huma: Parent of iPLATO and operator of myGP app, which embeds Lifelight. Comparable digital health platform addressing remote patient monitoring and preventive care; both serve NHS hypertension pathways.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat6 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/lifelight-ai/?originalSubdomain=uk
• Xx.com/lifelight_ai
• Facebookfacebook.com/lifelight.page

Compliance7 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds4 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Lifelight (Xim)